Kiniksa Pharmaceuticals International, plc Quarterly Current Ratio in % from Q1 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Kiniksa Pharmaceuticals International, plc quarterly Current Ratio history and growth rate from Q1 2019 to Q2 2024.
  • Kiniksa Pharmaceuticals International, plc Current Ratio for the quarter ending June 30, 2024 was 416 %, a 19% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 416 -97.4 -19% Jun 30, 2024
Q1 2024 458 -29.5 -6.04% Mar 31, 2024
Q4 2023 502 +64.6 +14.8% Dec 31, 2023
Q3 2023 529 +111 +26.4% Sep 30, 2023
Q2 2023 513 +55.2 +12.1% Jun 30, 2023
Q1 2023 488 -21.3 -4.19% Mar 31, 2023
Q4 2022 437 -171 -28.2% Dec 31, 2022
Q3 2022 418 -344 -45.1% Sep 30, 2022
Q2 2022 458 -483 -51.3% Jun 30, 2022
Q1 2022 509 -601 -54.1% Mar 31, 2022
Q4 2021 609 -622 -50.5% Dec 31, 2021
Q3 2021 762 -423 -35.7% Sep 30, 2021
Q2 2021 941 -95.7 -9.24% Jun 30, 2021
Q1 2021 1.11K +138 +14.2% Mar 31, 2021
Q4 2020 1.23K +299 +32% Dec 31, 2020
Q3 2020 1.19K +301 +34% Sep 30, 2020
Q2 2020 1.04K +102 +10.9% Jun 30, 2020
Q1 2020 972 -65 -6.27% Mar 31, 2020
Q4 2019 932 Dec 31, 2019
Q3 2019 885 Sep 30, 2019
Q2 2019 935 Jun 30, 2019
Q1 2019 1.04K Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.